December 2018 - Clinical trial profile - geography, diseases, sponsors -

Clinical Trials for Pregnyl

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00415766	Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders	Active, not recruiting	Eugonia	Phase 4	The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
NCT00415792	Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs	Unknown status	Eugonia	Phase 4	hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF cycles. These two approaches will be compared in this study in terms of pregnancy rates and embryological data using patients with hyper-response to IVF drugs.
NCT00627406	Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles	Completed	Regionshospitalet Viborg, Skive	Phase 4	The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles
NCT00809107	Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration	Completed	Universitair Ziekenhuis Brussel	N/A	The rational of the study is to assess the implantation, pregnancy and live birth rates after the transfer of frozen- thawed embryos in natural cycles with spontaneous Luteinizing Hormone (LH)/Progesterone rise or in natural cycles controlled by human chorionic gonadotropin (hCG) for final oocyte maturation and ovulation.
NCT00823004	Antagonist/Letrozole in Poor Responders	Completed	Yazd Research & Clinical Center for Infertility	Phase 1/Phase 2	Failure to respond to controlled ovarian hyperstimulation (COH) is still a major concern in assisted reproduction and there is no consensus on the ovarian stimulation choice regime for poor responders. Aim: To evaluate and compare the efficacy of a microdose GnRH agonist flare (MF) and a GnRH antagonist/letrozole (A/L) protocols in poor responders undergoing in vitro fertilization (IVF). Methods: One hundred eighty poor responder patients will be randomized to an ovarian stimulation protocol with either a MF or a letrozole and high dose FSH/hMG and flexible GnRH antagonist protocol.
NCT00823121	Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification	Unknown status	Yazd Research & Clinical Center for Infertility	Phase 1/Phase 2	Cryopreservation of all embryos and transferring them subsequently in assisted reproductive technology (ART) cycles to improve outcome.
NCT00839319	HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone	Completed	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 1/Phase 2	The purpose of this investigational study is to determine how much male hormone, testosterone, is necessary to maintain sperm production in the testis. This knowledge will be used to help in the development of a safe male hormonal contraception.
Trial ID	Title	Status	Sponsor	Phase	Summary